Tekedia Capital Welcomes Frekil, Scale AI for Medical Scans

Tekedia Capital invests in India-based Frekil. Frekil accelerates how healthcare AI teams procure and annotate medical scans such as X-rays, CT scans, fundus images, and more making the process up to 10x faster with AI-assisted workflows. The company partners with radiology networks to access large-scale imaging datasets and operates a global marketplace of certified radiologists who deliver rapid, high-quality annotations.

Globally, AI is reshaping healthcare, yet the biggest obstacle remains unchanged: access to clean, well-annotated medical images. Healthcare AI companies and life sciences R&D teams spend months collecting imaging data from hospitals and securing experts to annotate it. The annotation process itself remains manual, slow, expensive, and lacking transparency in quality.

Frekil was created to transform this bottleneck. Working closely with radiology partners, they source large volumes of imaging data and match them with Frekil’s worldwide network of vetted radiologists. On top of this supply chain, they have built powerful, browser-based annotation tools designed specifically for medical AI: collaborative, benchmark-driven, and FDA-ready from day one. With Frekil, teams can move from raw data to fully annotated, production-ready datasets in days instead of months.

This is Scale AI for medical scans and a foundational platform for healthcare innovation. Tekedia Capital welcomes Frekil.

Tekedia Capital invests in India-based Frekil. Frekil accelerates how healthcare AI teams procure and annotate medical scans such as X-rays, CT scans, fundus images, and more making the process up to 10x faster with AI-assisted workflows. The company partners with radiology… pic.twitter.com/XySUXpX2Gc

— Ndubuisi Ekekwe (@ndekekwe) November 20, 2025

Connect via my LinkedIn | Facebook | X | TikTok | Instagram | YouTube